Recently, MGI proprietary ultra-high-throughput genetic sequencer, DNBSEQ-T7*, was officially delivered to Wuhan Yingzi Gene to boost the company’s capacity in industry-university-research collaboration and innovation in molecular breeding.
DNBSEQ-T7 Features*
MGI’s DNBSEQ™ sequencing platform, DNBSEQ-T7*, supports four flow cells and can output 6TB of high-quality data per day. It is widely applicable to Whole Genome Sequencing, Deep Exome Sequencing, Transcriptome Sequencing, Molecular Breeding, and more.
Arrival and Impact
“We believe that with the high speed, flexibility, and ultra-high throughput advantages, the arrival of DNBSEQ-T7* will further strengthen our mass sample testing capacity and promote integration of industry-university-research in molecular breeding,” said Wuhan Yingzi Gene.
“We look forward to our new partnership with Yingzi Gene to facilitate high-throughput sequencing applications in molecular breeding, empower downstream users to overcome key technology barriers, and promote interconnected development of scientific research and industry,” added MGI.
About Wuhan Yingzi Gene
Wuhan Yingzi Gene was established on 17 May 2021, with support from Huazhong Agricultural University and experts in animal genetics and breeding. The company is committed to achieving breakthroughs in genetic breeding through industry-university-research integration.
Unless otherwise informed, all sequencers and sequencing reagents are not available in Germany, USA, Spain, UK, Hong Kong, Sweden, Belgium and Italy.
